カテゴリ： MarketLine, イスラエル, 企業調査

Teva Pharmaceutical Industries Limited：企業の戦略・SWOT・財務情報

◆英語タイトル：Teva Pharmaceutical Industries Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4430
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：63
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イスラエル
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥22,750見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥45,500見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥68,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Teva Pharmaceutical Industries Limited – Strategy, SWOT and Corporate Finance Report
Summary

Teva Pharmaceutical Industries Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Teva Pharmaceutical Industries Limited (Teva or ‘the company’) is a generic pharmaceutical company. Teva is engaged in the development, production and marketing of generic, proprietary branded pharmaceuticals and active pharmaceutical ingredients. The company conducts its operations primarily in the Americas, Europe and Asia. It is headquartered in Petach Tikva, Israel.

Scope

- Detailed information on Teva Pharmaceutical Industries Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Teva Pharmaceutical Industries Limited in the form of a SWOT analysis
- An in-depth view of the business model of Teva Pharmaceutical Industries Limited including a breakdown and examination of key business segments
- Intelligence on Teva Pharmaceutical Industries Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Teva Pharmaceutical Industries Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Teva Pharmaceutical Industries Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Teva Pharmaceutical Industries Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Teva Pharmaceutical Industries Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Teva Pharmaceutical Industries Limited: Company Overview 9
Teva Pharmaceutical Industries Limited: Overview and Key Facts 9
Teva Pharmaceutical Industries Limited: Overview 9
Teva Pharmaceutical Industries Limited: Key Facts 9
Teva Pharmaceutical Industries Limited: Key Employees 11
Teva Pharmaceutical Industries Limited: Key Employee Biographies 13
Teva Pharmaceutical Industries Limited: Major Products and Services 19
Teva Pharmaceutical Industries Limited: Company History 20
Teva Pharmaceutical Industries Limited: Management Statement 29
Teva Pharmaceutical Industries Limited: Locations and Subsidiaries 33
Teva Pharmaceutical Industries Limited: Key Competitors 34
Teva Pharmaceutical Industries Limited: Company Analysis 35
Teva Pharmaceutical Industries Limited: Business Description 35
Teva Pharmaceutical Industries Limited: SWOT Analysis 36
Teva Pharmaceutical Industries Limited: SWOT Overview 36
Teva Pharmaceutical Industries Limited: Strengths 36
Teva Pharmaceutical Industries Limited: Weaknesses 37
Teva Pharmaceutical Industries Limited: Opportunities 37
Teva Pharmaceutical Industries Limited: Threats 38
Teva Pharmaceutical Industries Limited: Corporate Financial Deals Activity 39
Teva Pharmaceutical Industries Limited: Financial Deals Overview 39
Teva Pharmaceutical Industries Limited: Targets and Partners 41
Teva Pharmaceutical Industries Limited: Top Deals 2014 – 2018YTD* 43
Teva Pharmaceutical Industries Limited: Advisors 44
Teva Pharmaceutical Industries Limited: Top Legal Advisors 44
Teva Pharmaceutical Industries Limited: Top Financial Advisors 44
Teva Pharmaceutical Industries Limited: Mergers and Acquisitions 46
Teva Pharmaceutical Industries Limited: Corporate Venturing 47
Teva Pharmaceutical Industries Limited: Capital Raising 48
Teva Pharmaceutical Industries Limited: Partnership 49
Teva Pharmaceutical Industries Limited: Divestments 50
Teva Pharmaceutical Industries Limited: Private Equity and Ownership 51
Teva Pharmaceutical Industries Limited: Recent Developments 52
Teva Pharmaceutical Industries Limited: News and Events Summary 52
Teva Pharmaceutical Industries Limited: Contracts 55
Teva Pharmaceutical Industries Limited: Financial Deals 57
Teva Pharmaceutical Industries Limited: Financial Performance 57
Teva Pharmaceutical Industries Limited: Red Flags/DistressSignals 58
Teva Pharmaceutical Industries Limited: Regulatory and Legal Events 59
Teva Pharmaceutical Industries Limited: Strategy and Operations 59
Appendix 61
Contact Us 61
Methodology 61
About MarketLine 62

List of Tables
Table 1: Teva Pharmaceutical Industries Limited: Key Facts
Table 2: Teva Pharmaceutical Industries Limited: Key Employees
Table 3: Teva Pharmaceutical Industries Limited: Locations and Subsidiaries
Table 4: Teva Pharmaceutical Industries Limited: Key Competitors
Table 5: Teva Pharmaceutical Industries Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Teva Pharmaceutical Industries Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Teva Pharmaceutical Industries Limited: M&A Average Deal Size - Value (US$m)
Table 8: Teva Pharmaceutical Industries Limited: Targets and Partners
Table 9: Teva Pharmaceutical Industries Limited: Top Deals 2014 - 2018YTD*
Table 10: Teva Pharmaceutical Industries Limited: Legal Advisor Ranking by Value (US$m)
Table 11: Teva Pharmaceutical Industries Limited: Financial Advisor Ranking by Value (US$m)
Table 12: Teva Pharmaceutical Industries Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Teva Pharmaceutical Industries Limited: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Teva Pharmaceutical Industries Limited: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: Teva Pharmaceutical Industries Limited: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: Teva Pharmaceutical Industries Limited: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 17: Teva Pharmaceutical Industries Limited: Capital Raising by Deal Type (2014 - YTD*2018)
Table 18: Teva Pharmaceutical Industries Limited: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 19: Teva Pharmaceutical Industries Limited: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 20: Teva Pharmaceutical Industries Limited: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 21: Teva Pharmaceutical Industries Limited: Divestments by Geography (2014 - YTD*2018)
Table 22: Teva Pharmaceutical Industries Limited: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 23: Teva Pharmaceutical Industries Limited: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 24: Teva Pharmaceutical Industries Limited: News and Events Summary
Table 25: Teva Pharmaceutical Industries Limited: Contracts
Table 26: Teva Pharmaceutical Industries Limited: Financial Deals
Table 27: Teva Pharmaceutical Industries Limited: Financial Performance
Table 28: Teva Pharmaceutical Industries Limited: Red Flags/DistressSignals
Table 29: Teva Pharmaceutical Industries Limited: Regulatory and Legal Events
Table 30: Teva Pharmaceutical Industries Limited: Strategy and Operations

List of Figures
Figure 1: Teva Pharmaceutical Industries Limited: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Teva Pharmaceutical Industries Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Teva Pharmaceutical Industries Limited: M&A Average Deal Size - Value (US$m)
Figure 4: Teva Pharmaceutical Industries Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Teva Pharmaceutical Industries Limited: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Teva Pharmaceutical Industries Limited: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 7: Teva Pharmaceutical Industries Limited: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 8: Teva Pharmaceutical Industries Limited: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 9: Teva Pharmaceutical Industries Limited: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 10: Teva Pharmaceutical Industries Limited: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 11: Teva Pharmaceutical Industries Limited: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 12: Teva Pharmaceutical Industries Limited: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 13: Teva Pharmaceutical Industries Limited: Divestments by Geography (2014 - YTD*2018)
Figure 14: Teva Pharmaceutical Industries Limited: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 15: Teva Pharmaceutical Industries Limited: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Teva Pharmaceutical Industries Limited：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • ANSYS Inc (ANSS)：企業の財務・戦略的SWOT分析
    ANSYS Inc (ANSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PDL Biopharma, Inc.：企業の戦略・SWOT・財務分析
    PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report Summary PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Exicure Inc (XCUR)：製薬・医療：M&Aディール及び事業提携情報
    Summary Exicure Inc (Exicure), formerly AuraSense Therapeutics LLC is a biotechnology company that discovers, develops, and commercializes immunomodulatory and gene silencing drugs based on 3-dimensional spherical nucleic acid constructs. The company’s technology portfolio includes SNA gene regulati …
  • TG Therapeutics Inc (TGTX)：製薬・医療：M&Aディール及び事業提携情報
    Summary TG Therapeutics Inc (TG Therapeutics) is a biopharmaceutical company which acquires, develops and commercializes pharmaceutical products for the treatment of B-cell malignancies and autoimmune diseases. The company develops two therapies, namely, TG-1101 (ublituximab) and TGR-1202 for the tr …
  • Achelios Therapeutics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Achelios Therapeutics Inc (Achelios) is a pharmaceutical company that develops therapeutics for the treatment of pain and inflammation by topically delivered medications. The company’s lead products include Topofen, a product for the indication of acute migraine, prophylactic migraine, osteo …
  • Illumina Inc (ILMN)-医療機器分野：企業M&A・提携分析
    Summary Illumina, Inc. (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; micro …
  • The Manitowoc Company Inc：企業の戦略・SWOT・財務分析
    The Manitowoc Company Inc - Strategy, SWOT and Corporate Finance Report Summary The Manitowoc Company Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • AIG Japan Holdings Kabushiki Kaisha：企業の戦略・SWOT・財務情報
    AIG Japan Holdings Kabushiki Kaisha - Strategy, SWOT and Corporate Finance Report Summary AIG Japan Holdings Kabushiki Kaisha - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Shermco Industries, Inc.-エネルギー分野：企業M&A・提携分析
    Summary Shermco Industries, Inc. (Shermco), a member of the GFI Energy Group of Oaktree Capital Management LP, is an independent service company that provides electrical maintenance, repair, testing, and analysis services for electrical systems and equipment. It also offers industrial contracting, u …
  • Maximus Inc.：企業の戦略・SWOT・財務情報
    Maximus Inc. - Strategy, SWOT and Corporate Finance Report Summary Maximus Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Bio-Reference Laboratories Inc：医療機器：M&Aディール及び事業提携情報
    Summary Bio-Reference Laboratories Inc (Bio-Reference) a subsidiary of Opko Health, Inc., is a full service clinical laboratory that specializes in genetic testing. The company provides comprehensive range of tests that focus on molecular diagnostics, genetics, anatomical pathology, oncology, and wo …
  • Allergan plc：企業のM&A・事業提携・投資動向
    Allergan plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Allergan plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Bank of America Corp：企業の戦略・SWOT・財務情報
    Bank of America Corp - Strategy, SWOT and Corporate Finance Report Summary Bank of America Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Protonex Technology Corporation：電力：M&Aディール及び事業提携情報
    Summary Protonex Technology Corporation (Protonex) is a fuel cell company, which carries out research, development and production of a wide range of power solutions. It principally offers advanced fuel cell power solutions for portable, remote and mobile applications. The company produces these prod …
  • GenomeDx Biosciences Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary GenomeDx Biosciences Inc (GenomeDx) is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers. The company offers decipher prostate cancer classifier, a transformative genomic test that provides an assessment of tumor agg …
  • InterGen：企業の戦略的SWOT分析
    InterGen - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Interprotein Corp-製薬・医療分野：企業M&A・提携分析
    Summary Interprotein Corp (Interprotein) is a drug discovery company that conducts research and develops small molecule drugs. The company provides IL-6 inhibitor, IgE inhibitor, notch1 inhibitor, tubulin polymerization inhibitors, TIM-3 inhibitor, NKG2A, HLA-E and CD94 inhibitor; KIR and HLA-C inhi …
  • Fidelity Life Assurance of Zimbabwe Ltd：企業の戦略・SWOT・財務情報
    Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report Summary Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Casey’s General Stores, Inc.：企業の戦略・SWOT・財務分析
    Casey's General Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Casey's General Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Hindalco Industries Ltd：企業の戦略・SWOT・財務情報
    Hindalco Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindalco Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆